CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

Net Sales by Sales Format

Ordinary Income

Net Income

Business Results Data (Cons.)

Unit:million yen

 
  FY 2016 FY 2017 FY 2018 FY 2019 FY 2020(Est.)
Net Sales 10,003 10,393 10,796 10,843 11,140

Cost of Sales
(% of Net Sales)

5,499
55.0%
5,471
52.6%
5,753
53.3%
5,615
51.8%
5,716
51.3%

Gross Profit
(% of Net Sales)

4,503
45.0%
4,922
47.4%
5,043
46.7%
5,228
48.2%
5,424
48.7%

SG&A expenses
(% of Net Sales)

3,748
37.5%
4,068
39.1%
4,049
37.5%
4,144
38.2%
4,334
38.9%

Operating Income 
(% of Net Sales)

754
7.5%
854
8.2%
993
9.2%
1,083
10.0%
1,090
9.8%

Ordinary Income 
(% of Net Sales)

821
8.2%
880
8.5%
999
9.3%
1,065
9.8%
1,100
9.9%

Net Income
(% of Net Sales)

516
5.2%
467
4.5%
672
6.2%
725
6.7%
750
6.7%

Net Sales by Sales Format(cons.)

Unit:million yen

  FY 2016 FY 2017 FY 2018 FY 2019 FY 2020(Est.)

Own-brand
(%)

6,263
62.6%
6,402
61.6%
6,558
60.7%
6,645
61.3%
6,750
60.6%
Overseas
(%)
1,954
19.6%
2,414
23.2%
2,715
25.2%
2,996
27.6%
3,086
27.7%
OEM Sales
(%)
1,784
17.8%
1,576
15.2%
1,522
14.1%
1,201
11.1%
1,304
11.7%
Total
(%)
10,003
100.0%
10,393
100.0%
10,796
100.0%
10,843
100.0%
11,140
100.0%

Graph Showing Financial Position

Free Cash Flow

Financial Position Data(cons.)

Unit:million yen

  
  FY 2016 FY 2017 FY 2018 FY 2019 FY 2020(Est.)

Current Assets

11,433 11,126 11,159 11,129 11,762

Fixed Assets

6,178 6,133 6,078 6,028 5,668

Total Assets
(Gross Assets)

17,611 17,259 17,237 17,157 17,430

Current Liabilities

3,294 3,052 2,914 2,651 2,726

Fixed Liabilities

1,713 1,337 1,437 1,330 1,227

Total Liabilities

5,007 4,390 4,351 3,982 3,953

Shareholders' Equity

12,603 12,868 12,886 13,175 13,477

Equity Ratio

71.6% 74.6% 74.8% 76.8% 77.3%

Cash Flow Data

Unit:million yen

  FY 2016 Fy 2017 FY 2018 FY 2019 FY 2020
(Est.)

Net cash provided by (used in) operating activities

1,443 524 797 880 1,124

Net cash provided by (used in) investing activities

△ 270 △ 193 △ 598 △ 511 △ 310

Net cash provided by (used in) financing activities

△ 332 △ 652 △ 585 △ 532 △ 511

Net increase(decrease)in cash and cash equivalents

719 △ 313 △ 484 △ 203 303

Cash and cash equivalents at end of year

4,427 4,114 3,629 3,426 4,500

Free Cash Flow

1,173 331 199 368 814
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2016 FY 2017 FY 2018 FY 2019 FY 2020(Est.)
ROE 4.0% 3.7% 5.2% 5.6% 5.6%
EPS(yen) 54.73 50.23 72.20 77.83 80.51
BPS(yen) 1,352.97 1,381.40 1,383.31 1,414.36 1,446.74

Dividend per Share (yen)

35 35 37 37 37

Dividend Payout Ratio(cons.)

64.0% 69.7% 51.2% 47.5% 46.0%

TOP